Siemens Healthineers eyes rebrand, separates in vitro diagnostic arm

Siemens Healthineers announced plans to separate its in vitro diagnostics business into a standalone company called Olyrian Diagnostics, expected to operate independently by 2028. The move represents a significant restructuring of the German healthcare conglomerate's portfolio, separating a major diagnostic testing and laboratory equipment line from its broader imaging and clinical systems business.